FDA Commissioner Dr. Makary on lifting HRT warnings: 50M women haven't experienced the benefits
FDA Commissioner Dr. Marty Makary joins 'Squawk box' to discuss questions around the use of female hormone replacement therapy, why the FDA is lifting warnings on HRT, future of women's health, and more.
Benzinga.com
STAT+: How the first nine drug companies won priority review vouchers from Marty Makary's FDA
WASHINGTON — Commissioner Marty Makary wants the Food and Drug Administration to move more quickly. The launch of a new priority review voucher program in June was no exception. The agency promised winners a one-to-two month review of their drug ...
US FDA unveils new pathway to approve personalized therapies
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the agency's top officials said on Wednesday.
FDA announces agency veteran will become top drug regulator after Tidmarsh resignation
The Food and Drug Administration on Tuesday announced 26-year agency veteran Richard Pazdur will replace a top regulator who resigned earlier this month amid accusations of abusing his power. Pazdur will be the director of the Center for Drug Evaluation and Research (CDER).
STAT
How the first nine drug companies won priority review vouchers from Marty Makary’s FDA
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Commissioner Marty Makary wants the Food and Drug Administration to ...
Feedback